Satellos Bioscience's total assets for Q4 2025 were C$31.83M, a decrease of -15.12% from the previous quarter. TSE:MSCL total liabilities were C$4.10M for the fiscal quarter, a 16.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.